Intriguingly, we found that the mRNA levels of low-risk genes NUCB1 and GCAT were elevated in tumor tissues more than those in normal tissues, but they were lower in stage IV than in stages I–III (Supplementary Figures S1H–I). This evidence concerns the gene GCAT and neoplasm.